Argitalpenak (27) JOSE ANGEL BEREZO GARCIA argitalpenak

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  2. Programa de optimización del uso de antimicrobianos en un Servicio de Medicina Intensiva: análisis retrospectivo observacional de los resultados 15 meses después de su implementación

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 477-485

2022

  1. Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

    Intensive Care Medicine, Vol. 48, Núm. 6, pp. 690-705

  2. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set

    Critical Care, Vol. 26, Núm. 1

  3. Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)

    Intensive Care Medicine

  4. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set (Critical Care, (2022), 26, 1, (236), 10.1186/s13054-022-04108-8)

    Critical Care

  5. Determinants of mortality in cancer patients with unscheduled admission to the Intensive Care Unit: A prospective multicenter study

    Medicina Intensiva, Vol. 46, Núm. 12, pp. 669-679

  6. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  3. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events

    Internal and Emergency Medicine, Vol. 15, Núm. 8, pp. 1533-1544

  2. The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database

    Critical Care, Vol. 24, Núm. 1

  3. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2018

  1. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

    Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344

  2. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

  3. Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study

    Critical Care, Vol. 22, Núm. 1

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2014

  1. Assessment of the worldwide burden of critical illness: The Intensive Care Over Nations (ICON) audit

    The Lancet Respiratory Medicine, Vol. 2, Núm. 5, pp. 380-386

  2. Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma

    Journal of Pain and Symptom Management